This novel microtubule/Top2 inhibitor was shown to inhibit both microtubule and Top2, result in microtubule depolymerization and DSB, subsequently lead to mitotic arrest and apoptosis and finally elicit tumor proliferation and growth inhibition in vitro and in vivo. Here, TOP2A is linked to neoplasm.